- Center on Health Equity & Access
- Clinical
- Health Care Cost
- Health Care Delivery
- Insurance
- Policy
- Technology
- Value-Based Care
Michele McCourt Discusses Impact of High Costs for Patients With Cancer
High costs in cancer care not only affects treatment outcomes for patients, but also their overall quality of life, explained Michele McCourt, senior director of the CancerCare Co-Payment Assistance Foundation.
High costs in cancer care not only affects treatment outcomes for patients, but also their overall quality of life, explained Michele McCourt, senior director of the CancerCare Co-Payment Assistance Foundation.
Transcript
What is the impact of high costs on access to care for patients with cancer?
Patients with cancer, we actually do a survey. Patients with cancer, the high costs, it’s referred to as financial toxicity. It affects their overall quality of life in a negative way. It impacts their quality of life and they’re having to make tough choices. So, patients will either walk away from treatment, they will try and take their medications spread out over time so they aren’t taking their medications properly so they aren’t adhering to the way they are supposed to take their medication and it’s becoming ineffective. It really affects their quality of life.
The other thing is they might be taking because they don’t want to take the medication that really works best for them, they might choose a medication that has different treatment side effects. So, making those tough choices just to save as much money as they can, it negatively impacts their life.
Exploring Racial, Ethnic Disparities in Cancer Care Prior Authorization Decisions
October 24th 2024On this episode of Managed Care Cast, we're talking with the author of a study published in the October 2024 issue of The American Journal of Managed Care® that explored prior authorization decisions in cancer care by race and ethnicity for commercially insured patients.
Listen
Examining Low-Value Cancer Care Trends Amidst the COVID-19 Pandemic
April 25th 2024On this episode of Managed Care Cast, we're talking with the authors of a study published in the April 2024 issue of The American Journal of Managed Care® about their findings on the rates of low-value cancer care services throughout the COVID-19 pandemic.
Listen
Key Indicators of Myasthenia Gravis Disease Progression Reduced With Efgartigimod
April 18th 2025Research presented at the recent annual meeting of the Academy of Managed Care Pharmacy highlights outcomes among patients who have anti-acetylcholine receptor antibody-positive myasthenia gravis that include reduced exacerbations and need for immunoglobulin.
Read More
